Cargando…
Analysis of Urinary Glycosaminoglycans to Predict Outcome in COVID-19 and Community-Acquired Pneumonia—A Proof-of-Concept Study
Although coronavirus disease 2019 (COVID-19) is considered a systemic disease associated with vascular inflammation and eventual destruction of the protective endothelial glycocalyx (eGC), biomarkers of eGC damage are not yet available in the clinic. The most prominent components of eGC are sulphate...
Autores principales: | Rovas, Alexandros, Neumann, Julia Katharina, Drost, Carolin Christina, Vollenberg, Richard, Thölking, Gerold, Fobker, Manfred, Witzenrath, Martin, Kümpers, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455319/ https://www.ncbi.nlm.nih.gov/pubmed/37629312 http://dx.doi.org/10.3390/jcm12165269 |
Ejemplares similares
-
Protection and rebuilding of the endothelial glycocalyx in sepsis – Science or fiction?
por: Drost, Carolin Christina, et al.
Publicado: (2021) -
Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study
por: Rovas, Alexandros, et al.
Publicado: (2022) -
Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 – A Proof-of-Concept Study
por: Drost, Carolin Christina, et al.
Publicado: (2022) -
Microvascular dysfunction in COVID-19: the MYSTIC study
por: Rovas, Alexandros, et al.
Publicado: (2020) -
Störung der Mikrozirkulation bei COVID-19
por: Rovas, Alexandros, et al.
Publicado: (2021)